0.21Open0.21Pre Close0 Volume19 Open Interest175.00Strike Price0.00Turnover361.08%IV129.30%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.21Extrinsic Value100Contract SizeAmericanOptions Type0.0221Delta0.0018Gamma363.86Leverage Ratio-0.1448Theta0.0002Rho8.06Eff Leverage0.0042Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet